Binge Drinking: According to a rent study conducted by Kathryn Graham, et al of the University of Western Ontario psychology department "Depression is most strongly related to a pattern of binge drinking,"
Binge Drinking is defined in the study as consuming at least 5 alcoholic beverages at one sitting.
Whether Binge Drinking resulted in the development depression or whether depression contributed to a persons binge drinking was unclear in this study.
Alcohol Addiction
Alcohol Addiction is a chronic disease characterized by a strong craving for alcohol, a constant or periodic reliance on use of alcohol despite adverse consequences, the inability to limit drinking, physical illness when drinking is stopped, and the need for increasing amounts of alcohol to feel its effects. Inpatient Treatment is most often residential in that they require that the client live within the facility during treatment. Inpatient treatment centers and programs are a higher level of care than outpatient programs and provide more intensive services and treatment than lower levels of the care continuum.Alcoholism and Drug Addiction Intervention A drug and alcoholism intervention is an attempt by family members and friends to help a chemically dependent person get help for his or her addiction.
Crystal Methamphetamine (Meth) Addiction and Treatment in Club Drugs
Crystal Methamphetamine (Meth) Addiction and Treatment
In 1893, methamphetamine (meth) was first synthesized from ephedrine by Japanese chemist, Nagayoshi Nagai. In 1919, Akira Ogata synthesized crystallized meth by reducing ephedrine using red phosphorous and iodine.1 In the 1950s, Pharmacology and Therapeutics reported legal prescriptions of methamphetamine given to the American public for the treatment of narcolepsy, post-encephalitic Parkinsonism, alcoholism, and obesity.2
Meth is an extremely potent stimulant that works within the central neverous system and affects the bodies neurochemical mechanisms that are responsible for regulating appetite, heart rate, blood pressure, body temperature, blood pressure, attention, mood and automatic responses such as alertness or alarm. Methamphetamine causes the norempinephrine transporter and the dopamine transporter to switch their direction of flow. This switch causes a release of these transmitters from the vesicles to the cytoplasm and from the cytoplasm to the synapse, causing increased stimulation of post-synaptic receptors. In addition, Meth indirecly prevents the reuptake of these neurotransmitters, causing them to remain in the synaptic cleft.3 It is neurotoxic in overdose.4
Because the "high" that methamphetamine gives is intense and can last from eight to 24 hours, it has replaced cocaine, heroin, and marijuana as the drug of choice in many areas. Known on the street as "speed," "meth," "ice," and "crystal," it can be injected, smoked, snorted, or swallowed. During an interview with Dr. David McDowell, M.D.,(medical director of the Substance Treatment and Research Service at Columbia University at the New York State Psychiatric Institute)states, "The timing and intensity of the ‘rush’ are a result of the release of high levels of dopamine in the brain. Methods that cause methamphetamine to pass into the brain more quickly—smoking or injecting—are more reinforcing and more addiction."5
There are several serious physical and psychological risks involved when using crystal meth including: increased blood pressure, rapid heart rate, inflammation of the heart lining, damage to small blood vessels in the brain which can lead to stroke, episodes of violent behavior, anxiety, paranoia, insomnia, and confusion.6 Intravenous users also expose themselves to risks such as human immunodeficiency virus (HIV), hepatitis B and C, blood-borne viruses, scarred and collapsed veins, infections of the heart lining and valves, abscesses, pneumonia, tuberculosis, and liver or kidney disease. After using meth, the addict crashes which can cause feelings of depression and suicide. After discontinuing use, Crystal meth addicts can have continuous psychotic symptoms that persist for months and years.
According to the United States Department of Justice Drug Enforcement Agency (DEA) and under the Controlled Substance Act (CSA), all controlled substances are rated on a five-schedule system. Schedule V, the lowest, for the potential for abuse and dependency and I, the highest. Crystal meth is a Schedule II controlled substance having the following attributes: a high potential for abuse, severe psychological and physical dependence. Other drugs in this category are cocaine and PCP.7
Behavioral intervention is the most effective treatment for crystal meth addiction. These approaches are designed to help modify the patient's thinking, their expectancies, and behaviors, and to increase skills in coping with various life stressors. Meth recovery support groups such as 12-step programs are also effective adjuncts to behavioral interventions that can lead to long-term drug-free recovery. There are currently no particular pharmacological treatments for dependence on amphetamine or amphetamine-like drugs such as methamphetamine.8 There are also numerous treatment obstacles such as: paranoia, decreased social skills, delusions, depression, malnutrition, violence, aggression, permanent psychological problems, kidney and lung disorders, liver damage, hallucinations, and feeling of suicide.9
In conclusion, crystal methamphetamine continues to plague our world and recovery from this hazardous drug proves to be among the most difficult habits to break. Education is a must if society desires to demolish these trends. Education and awareness is key to stopping the crystal meth epidemic today, tomorrow and years to come.
This article was last modified on 12/15/2006.
References
1. Yudko, Errol, Harold V. Hall and Sandra McPherson, Methamphetamine use: clinical and forensic aspects, Boca Raton, FL: CRC Press, 2003.
2. Wright, Harold N., Montag, Mildred, Pharmacology and therapeutics, Philadelphia, PA: W.B. Saunders Company, 1951.
3. Rothman, R.B., Baumann. M.H. Pharmacology and therapeutics 2002:95, 73-85.
4. Itzhak Y, Martin J, Ali S (2002). "Methamphetamine-induced dopaminergic neurotoxicity in mice: long-lasting sensitization to the locomotor stimulation and desensitization to the rewarding effects of methamphetamine.". Prog Neuropsychopharmacol Biol Psychiatry 26 (6): 1177-83.
5. Milne D., Experts desperately seeking meth abuse prevention, treatment. Psychiatric News, Jan 2, 2003, Volume 38 issue 1.
6. http://www.usdoj.gov/dea/pubs/publications.html
The Controlled Substances Act: Chapter 1.
7. http://www.dea.gov/pubs/csa.html
DEA: Controlled Substances Act: Drug Abuse Prevention and Control.
8. http://parentingteens.about.com/cs/meth/l/blmeth5.htm
9. Lee, Steven J, Overcoming crystal meth addiction: an essential guide to getting clean from crystal meth addiction, New York: Marlowe & Company, 2006.
This website is dedicated to providing quality chemical
dependency and addiction related resources and rehab
center listings so you can make an informed
decision that can alter the course of your life or that of your
loved one. For immediate assistance call our toll free helpline
at 800-559-9503 or you can go to our form and fill out an inquiry
and we will get back to you.
Treatment and Addiction Articles Feed
